Cardiovascular Safety of Atomoxetine and Methylphenidate in ADHD Patients: Japanese Claims Database Study

StudiuADHDÎncredere bună

A large self-controlled case series study in Japan examined cardiac safety of two common ADHD medications in over 27,000 patients. Atomoxetine showed increased arrhythmia risk in the first week and upon re-exposure, while methylphenidate showed no such association; monitoring for arrhythmia is recommended when initiating atomoxetine.

Sources

MED — Tue Dec 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Read full article (translated)

Afișăm titlu + rezumat scurt în limita dreptului de autor; textul integral e la sursă.